• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Medicare Use of Telehealth During COVID-19


Medicare beneficiary use of telehealth services reached nearly 9 million as COVID-19 shut down on-site visits. Will the options be permanent?

Use of telehealth by US Medicare beneficiaries during the early weeks of the COVID-19 pandemic reached more than 9 million as in-person clinical contact quickly become impossible, according to data from the Centers for Medicare & Medicaid Services (CMS). CMS also reports that weekly telehealth visits jumped from 13 000 pre-pandemic to nearly 1.7 million in April.

In a July 15 commentary in Health Affairs, CMS administrator Seema Verma elaborated on the swift adoption of "connected health" from March 17-June 30. As to the future of state and federal rules relaxed to encourage uptake, Verma said CMS is “reviewing the temporary changes we made and assessing which of these flexibilities should be made permanent through regulatory action.”

The short slide show below highlights the demographcis of telehealth use among Medicare beneficiaries and the issues CMS is considering before deciding on permanent changes.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
© 2024 MJH Life Sciences

All rights reserved.